We confirmed that ABI3 was expressed in follicular carcinomas cells only when these specific CpG sites located at the promoter region of ABI3 (R1 region) were demethylated and NKX2-1 was present. The gene discussed is NKX2-1; the disease is thyroid gland follicular carcinoma.